UNSPSC 51191583: Triflocin sodium

This classification denotes the sodium form of a diuretic with the molecular formula C13H9F3N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S01B3A38SK, chemically known as 4-(alpha,alpha,alpha-trifluoro-m-toluidino)nicotinic acid but more generally known as triflocin, which bears US NIH Compound Identifier 25969. European Medicines Agency schedules Triflocin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11284MIG.

UNSPSC 51191583 Triflocin sodium is a Commodity code that in recent state and local procurement activity describes chemical supplies for water treatment and pharmaceutical products procured through cooperative purchasing agreements. State and local governments buy sodium bisulfite and related chemical compounds for water pollution control facilities and municipal water treatment operations, where these substances serve critical roles in treatment processes. The issuing bodies include municipal water departments, state agencies administering cooperative purchasing consortia, and participating government facilities across multiple jurisdictions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents a significant mechanism for distributing pharmaceutical and chemical products to state and local government entities across multiple states including Oregon.

Recent activity concentrates in Connecticut and Minnesota, with the City of Meriden issuing an IFB for sodium bisulfite supply for its Water Pollution Control Facility with bids due July 29, 2026 (Solicitation B027-15), and MMCAP issuing an RFP to establish multiple contracts for generic pharmaceuticals and OTC products with proposals due March 26, 2026 (Solicitation S1070000015802). The MMCAP procurement requires vendors to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with awarded vendors effective July 1, 2026. Vendors must maintain commercial general liability coverage of $5,000,000 per occurrence and professional liability of $2,000,000, certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, and accept a 3 percent administrative fee on all contract purchases. The Meriden solicitation requires performance and labor-and-material payment bonds, with General Liability coverage of $1,000,000 to $2,000,000 and Connecticut-approved carriers.